TELA Bio, Inc.
TELA
NASDAQ·Healthcare·Medical - Devices·Mkt cap $36.8M
$0.82
▲ +5.19%
P/E
-2.00
Mkt Cap
$36.8M
52-Wk Range
$0.50–$1.73
52-Week Range
$0.50 - $1.73
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 49.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Weak
-6.7% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying TELA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 10, 2026
Reported EPS of -$0.20 vs -$0.17 consensus (-15.1% surprise). Revenue of $19.3M vs $20.0M expected (-3.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-15.1%
Revenue trend · last 2Q
—
-4%
Q1 26
Q2 26
$19.1M
$19.3M
Margins · last 2Q
Gross
72.3%
Operating
-48.1%
Profit
-58.4%
Wall Street consensus
4 analysts · 75% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
—
Latest: Citizens · Mar 27, 2026
vs Industry
How TELA stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.